Reviewed by the Celnovix Editorial Team
Last reviewed: September 2026
Urolithin A has become one of the most discussed compounds in the healthy-aging and mitochondrial-health space.
You may have seen it described as:
- A mitochondrial supplement
- A mitophagy activator
- A postbiotic
- A muscle-aging supplement
- A longevity compound
Some of those descriptions reflect genuine areas of scientific research.
Others go much further than the current human evidence supports.
So what exactly is Urolithin A?
Urolithin A is a metabolite that certain gut bacteria can produce after metabolizing dietary compounds called:
- Ellagitannins
- Ellagic acid
These compounds occur in foods such as:
- Pomegranates
- Walnuts
- Raspberries
- Strawberries
- Blackberries
But an important detail is often missed:
Eating these foods does not guarantee that your body will produce meaningful amounts of Urolithin A.
Production depends heavily on the composition of your gut microbiome.
That biological variability is one reason direct Urolithin A supplementation has become an area of research.
Key Takeaways
- Urolithin A is a gut microbiome-derived metabolite.
- It is formed from ellagitannin and ellagic-acid precursors rather than being present in most foods in meaningful amounts as free Urolithin A.
- Not everyone produces Urolithin A efficiently after eating precursor-rich foods.
- Urolithin A is studied primarily for its relationship with mitophagy and mitochondrial quality control.
- Human randomized trials have reported some improvements in muscle endurance, strength and mitochondrial-related biomarkers.
- Several important primary outcomes in human trials have not significantly improved versus placebo.
- Current evidence does not prove that Urolithin A reverses aging or extends human lifespan.
- Most intervention studies are relatively short and involve modest sample sizes.
- Long-term human evidence remains limited.
- Study doses should not automatically be treated as personal recommendations.
What Is Urolithin A?
Urolithin A is a compound generated through metabolism of dietary polyphenol precursors.
The simplified pathway is:
Ellagitannins / Ellagic Acid
↓
Gut Microbiome
↓
Intermediate Urolithins
↓
Urolithin A
Foods rich in ellagitannins and ellagic acid provide the starting material.
But the gut microbiome determines whether those precursors are efficiently converted.
This is why two people can eat the same pomegranate and produce very different amounts of Urolithin A.
Is Urolithin A a Vitamin?
No.
Urolithin A is not:
- A vitamin
- A mineral
- An essential nutrient
There is no established dietary requirement for Urolithin A.
It is better described as a:
microbiome-derived metabolite
or, in some commercial contexts, a:
postbiotic metabolite.
Is Urolithin A a Postbiotic?
It is frequently described that way.
A postbiotic broadly refers to bioactive substances associated with microbial metabolism rather than live microorganisms themselves.
Urolithin A fits that concept because:
- It is not a probiotic bacterium.
- It is not a prebiotic fiber.
- It is produced through microbial metabolism.
That makes it fundamentally different from:
- Probiotics
- Prebiotics
- Digestive enzymes
Where Does Urolithin A Come From?
Urolithin A production starts with foods containing ellagitannins or ellagic acid.
Important precursor sources include:
- Pomegranate
- Walnuts
- Raspberries
- Strawberries
- Blackberries
- Certain other berries and nuts
But these foods primarily provide precursors.
They are not reliable direct sources of preformed Urolithin A.
For a deeper explanation:
Foods Rich in Urolithin A: Natural Sources and What to Know
Why Doesn’t Everyone Produce Urolithin A?
The answer lies in the gut microbiome.
Different people have different communities of intestinal microorganisms.
Only certain microbial configurations appear capable of efficiently converting ellagic-acid-related compounds into Urolithin A.
Researchers sometimes describe different individuals as having different:
urolithin metabotypes.
This helps explain why dietary precursor intake does not translate into predictable Urolithin A exposure for everyone.
What Are Urolithin Metabotypes?
A metabotype refers to the pattern of urolithins an individual produces after consuming ellagitannin-rich foods.
Some people produce substantial Urolithin A.
Others produce:
- Different urolithins
- Smaller amounts
- Little detectable Urolithin A
This variation appears to be influenced mainly by the gut microbiome.
Why Is Urolithin A Studied for Healthy Aging?
The main scientific interest centers on:
mitochondrial quality control.
Mitochondria are cellular structures involved in processes including:
- ATP production
- Energy metabolism
- Cellular signaling
- Redox biology
Like other cellular components, mitochondria can become damaged or dysfunctional.
Cells therefore have quality-control systems for identifying and recycling damaged components.
One of those processes is:
mitophagy.
What Is Mitophagy?
Mitophagy is a selective form of autophagy.
In simple terms:
autophagy
is a broader cellular recycling system.
mitophagy
specifically refers to selective removal and recycling of mitochondria.
A simplified model is:
Damaged mitochondrion
↓
Recognition
↓
Isolation
↓
Lysosomal degradation
↓
Recycling of cellular components
This is one mechanism through which cells maintain mitochondrial quality.
Does Urolithin A Activate Mitophagy?
Preclinical research strongly supports a relationship between Urolithin A and mitophagy-related pathways.
Human studies provide evidence that Urolithin A can alter:
- Mitochondrial gene expression
- Acylcarnitine profiles
- Selected autophagy-related biomarkers
- Proteins associated with mitochondrial metabolism
But there is an important distinction:
Demonstrating changes in biomarkers associated with mitophagy is not the same as proving that a supplement rejuvenates mitochondria throughout the human body.
This distinction matters for YMYL accuracy.
What Does Human Research Show?
The human evidence base is growing but remains relatively small.
A 2024 systematic review identified:
5 human studies involving approximately 250 healthy participants.
Doses ranged from:
10–1,000 mg/day
with intervention periods ranging from:
28 days to 4 months.
The review reported findings involving:
- Some mitochondrial gene-expression changes
- Selected autophagy markers
- Fatty-acid oxidation pathways
- Inflammatory biomarkers
- Muscle strength
- Muscle endurance
However, Urolithin A did not consistently improve:
- Maximal mitochondrial ATP production
- Mitochondrial biogenesis
- Mitochondrial dynamics
- Cardiovascular outcomes
- Anthropometric outcomes
- Overall physical function
View the systematic review on PubMed
That mixed pattern is important.
First-in-Human Urolithin A Trial
One of the foundational human studies examined Urolithin A in healthy sedentary older adults.
Participants received either:
- Single doses
or:
- Repeated doses for four weeks.
Researchers found that Urolithin A was bioavailable and generally well tolerated under the study conditions.
Daily doses of:
500 mg and 1,000 mg
were associated with changes in:
- Plasma acylcarnitines
- Skeletal-muscle mitochondrial gene expression
These were primarily molecular and biomarker findings.
This trial helped establish human bioavailability.
But it did not prove lifespan extension or reversal of aging.
Urolithin A in Older Adults
A randomized clinical trial published in JAMA Network Open studied:
66 adults aged 65–90 years.
Participants received:
1,000 mg Urolithin A daily
or placebo for:
4 months.
Researchers evaluated primary outcomes including:
- Six-minute walking distance
- Maximal ATP production in skeletal muscle
The Urolithin A group did not show statistically significant improvement versus placebo for those primary outcomes.
However, several secondary findings were more favorable.
Urolithin A significantly improved muscle endurance in:
- Hand muscle
- Leg muscle
at certain time points.
Changes were also observed in:
- Acylcarnitines
- Ceramides
- C-reactive protein
View the randomized trial on PubMed
This is a good example of why headlines can be misleading.
Did Urolithin A Improve Walking Distance?
The trial showed an increase in six-minute walking distance within the Urolithin A group.
But the difference versus placebo was not statistically significant for the study’s primary walking outcome.
That means it would be inaccurate to say:
“Urolithin A has been proven to significantly improve walking ability in older adults.”
The result is more nuanced.
Did Urolithin A Improve ATP Production?
Not significantly in that older-adult trial.
Maximal ATP production was one of the study’s primary endpoints.
The between-group differences were not significant.
This matters because Urolithin A is often marketed simply as:
“boosting mitochondrial ATP production.”
Current human evidence does not justify that broad claim.
Urolithin A and Muscle Endurance
Muscle endurance is one of the more interesting human findings.
In the older-adult trial, participants receiving Urolithin A showed improvements in the number of contractions certain muscles could perform before fatigue.
That suggests potential relevance to:
- Muscle endurance
- Age-related muscle function
But it should not be confused with:
- Large muscle growth
- Treatment of sarcopenia
- Guaranteed improvements in everyday mobility
Urolithin A in Middle-Aged Adults
Another randomized, placebo-controlled trial studied middle-aged adults who were overweight.
Participants received:
- 500 mg/day
- 1,000 mg/day
- Placebo
for:
4 months.
Researchers reported favorable findings involving:
- Some muscle-strength measures
- Selected endurance or exercise outcomes
- Mitochondrial biomarkers
- Inflammatory markers
However, the study’s primary outcome—peak power output—did not significantly improve.
Again, the evidence is encouraging but not uniformly positive.
Does Urolithin A Increase Muscle Strength?
Some randomized trials report improvements in selected strength measures.
The middle-aged-adult trial reported approximately:
12% improvements in certain muscle-strength outcomes
with Urolithin A.
But:
- Not every endpoint improved.
- Study populations were specific.
- Some studies had industry involvement.
The correct conclusion is:
Urolithin A may support selected muscle outcomes in some populations, but it is not established as a general muscle-building supplement.
Does Urolithin A Build Muscle Mass?
Current evidence does not support presenting Urolithin A as a muscle-building compound comparable with:
- Resistance training
- Adequate protein
- Creatine
The human research focuses more on:
- Muscle function
- Endurance
- Strength
- Mitochondrial biomarkers
than substantial increases in muscle mass.
Urolithin A vs Creatine for Muscle
These supplements are very different.
Creatine
Has a large evidence base involving:
- Strength
- High-intensity performance
- Resistance-training adaptation
- Lean tissue
Urolithin A
Has a smaller emerging evidence base involving:
- Mitophagy
- Mitochondrial quality control
- Muscle endurance
- Selected strength outcomes
If the specific goal is:
maintaining muscle and strength with age
resistance training remains the foundation, and creatine currently has more direct exercise-performance evidence.
Read:
Creatine for Healthy Muscle Aging
Urolithin A and Healthy Muscle Aging
Urolithin A fits naturally into research on healthy muscle aging because:
- Muscle is highly dependent on mitochondrial function.
- Mitochondrial quality can change with age.
- Mitophagy is involved in mitochondrial turnover.
- Human studies have evaluated muscle outcomes.
But healthy muscle aging depends much more heavily on:
- Resistance training
- Protein intake
- Total nutrition
- Physical activity
- Recovery
For the broader strategy:
How to Maintain Muscle Mass After 50
What Does the 2026 Meta-Analysis Show?
A newer systematic review and meta-analysis evaluated randomized controlled trials of oral Urolithin A supplementation and muscle-related outcomes.
The review included trials published through December 2025.
Only the:
six-minute walk test
had enough comparable data for quantitative pooling.
The pooled result suggested approximately:
17 meters of improvement
but the confidence interval crossed zero and the result was not statistically significant.
Evidence certainty was rated low.
Other endpoints had to be synthesized narratively because the studies were too heterogeneous.
View the 2026 meta-analysis on PubMed
The implication is clear:
There are promising signals, but human evidence is not yet strong enough to describe Urolithin A as a proven therapy for muscle aging.
Does Urolithin A Increase Longevity?
This has not been demonstrated in humans.
Animal studies have produced interesting findings related to:
- Lifespan
- Healthspan
- Muscle function
But animal longevity results cannot be directly translated into human lifespan claims.
The 2024 systematic review specifically concluded that effects on human healthspan and lifespan require further research.
Does Urolithin A Reverse Aging?
No human evidence establishes that.
Terms such as:
- Anti-aging
- Age reversal
- Cellular rejuvenation
are often used loosely in supplement marketing.
Urolithin A is better described as:
a compound being studied for mitochondrial quality-control pathways and selected muscle-related outcomes.
That statement is scientifically stronger because it reflects what has actually been measured.
Does Urolithin A Lower Biological Age?
There is currently insufficient evidence to say that Urolithin A reliably lowers validated biological-age measures in humans.
Changes in mitochondrial biomarkers should not be automatically interpreted as:
younger biological age.
Urolithin A and Inflammation
Some human studies have reported changes in inflammatory biomarkers.
For example, trials have reported reductions in:
- C-reactive protein
- Selected inflammatory-related markers
The 2024 systematic review also identified dose-related anti-inflammatory signals.
However:
Urolithin A should not be described as an established treatment for inflammatory disease.
Biomarker changes are not the same as treating a diagnosed condition.
Urolithin A and Mitochondrial Biomarkers
Human trials have observed changes involving:
- Acylcarnitines
- Mitochondrial gene expression
- Mitophagy-related proteins
- Fatty-acid oxidation pathways
These findings provide evidence of biological activity.
But they should not be translated into claims such as:
“Urolithin A completely renews your mitochondria.”
The biology is more complex.
Does Urolithin A Create New Mitochondria?
Not exactly.
This is a common misunderstanding.
Mitophagy primarily concerns:
removal and recycling of damaged mitochondria.
Mitochondrial biogenesis concerns:
formation of new mitochondrial components.
They are related aspects of mitochondrial turnover but are not the same process.
The 2024 systematic review did not find consistent evidence that Urolithin A significantly increased mitochondrial biogenesis in humans.
Does Urolithin A Repair Mitochondria?
“Repair” is an oversimplification.
Urolithin A is primarily studied around:
mitochondrial quality-control pathways
rather than directly fixing each damaged mitochondrion.
A more accurate model is:
Mitochondrial damage
↓
Quality-control signaling
↓
Mitophagy / recycling
↓
Maintenance of mitochondrial network quality
Even that is still a simplified representation.
Urolithin A vs NMN
These compounds are often grouped together under “longevity,” but they target different biology.
NMN
Primary research focus:
NAD+ metabolism
NMN is a precursor involved in NAD+ biosynthesis.
Urolithin A
Primary research focus:
Mitophagy and mitochondrial quality control
Neither is universally better.
Their evidence bases address different mechanisms and outcomes.
Read the complete comparison:
NMN vs Urolithin A: Which Is Better for Healthy Aging?
Can You Take NMN and Urolithin A Together?
There is no strong evidence establishing that the combination is inherently incompatible.
But there is also insufficient evidence proving that:
NMN + Urolithin A
produces superior clinical outcomes compared with either compound alone.
Different mechanisms do not automatically create synergy.
Read:
Can You Take NMN and Urolithin A Together?
Urolithin A vs CoQ10
Both are often marketed for mitochondrial health.
But their biological roles differ substantially.
Urolithin A
Research emphasis:
- Mitophagy
- Mitochondrial quality control
CoQ10
Established biological role:
- Electron transport chain
- Oxidative phosphorylation
- Redox biology
There is no strong direct human head-to-head trial showing one is universally superior.
Read:
Urolithin A vs CoQ10: What’s the Difference and Which Is Better?
Urolithin A vs Resveratrol
Resveratrol and Urolithin A are also frequently compared in longevity discussions.
Resveratrol
Research spans:
- Metabolic signaling
- Polyphenol biology
- Cardiovascular endpoints
- Inflammatory pathways
Urolithin A
Research focuses more specifically on:
- Mitophagy
- Muscle
- Mitochondrial quality control
Neither has been proven to extend human lifespan.
Read:
Urolithin A vs Resveratrol: Which Longevity Supplement Should You Choose?
Can You Get Urolithin A From Pomegranate?
Indirectly.
Pomegranate contains:
- Ellagitannins
- Ellagic acid
These can serve as precursors.
Your gut microbiome may then convert them into Urolithin A.
But:
pomegranate itself is not a predictable dose of Urolithin A.
Can You Get Urolithin A From Walnuts?
The same principle applies.
Walnuts contain precursor compounds.
But the amount of Urolithin A ultimately produced depends on microbial metabolism.
Eating walnuts therefore cannot guarantee a specific Urolithin A exposure.
Which Foods Are Highest in Urolithin A?
This wording is slightly misleading.
Foods are better described as being rich in:
Urolithin A precursors
rather than Urolithin A itself.
Important examples include:
- Pomegranate
- Walnuts
- Certain berries
For the complete list:
Foods Rich in Urolithin A: Natural Sources and What to Know
What If You Don’t Produce Urolithin A Naturally?
This is one reason direct Urolithin A supplementation has been studied.
A direct supplement bypasses the need for gut bacteria to convert dietary precursors into the final metabolite.
But this does not mean everyone needs supplementation.
A person’s ability to produce Urolithin A naturally is not currently a routine clinical diagnosis.
How Much Urolithin A Has Been Studied?
Human studies have used different doses.
Examples include:
- 250 mg
- 500 mg
- 1,000 mg
- Higher single doses in early safety work
But these are:
research doses
not universal medical recommendations.
The appropriate intake cannot be determined solely from a study protocol.
For the dedicated article:
Urolithin A Dosage Guide: How Much Urolithin A Should You Take?
Is 500 mg Urolithin A Enough?
Some clinical studies used 500 mg/day.
Others used 1,000 mg/day.
Current evidence does not establish a universal:
minimum effective dose
for every desired outcome.
More is not automatically better.
Is 1,000 mg Urolithin A Better Than 500 mg?
Not necessarily for every endpoint.
Some studies have evaluated both doses.
Responses can vary according to:
- Outcome
- Population
- Duration
A higher study dose does not automatically produce superior clinically meaningful results.
Best Time to Take Urolithin A
There is no high-quality evidence establishing one universally superior time.
Human trials have demonstrated effects using regular daily supplementation but do not show that:
- Morning
- Night
- Pre-workout
- Post-workout
is universally superior.
Consistency may be more relevant than exact clock timing.
Read:
Best Time to Take Urolithin A: Morning or Night?
Should You Take Urolithin A With Food?
Current evidence does not provide a universal food-timing rule applicable to every formulation.
Follow:
- Product-specific instructions
- Relevant healthcare guidance
rather than assuming fasting improves absorption.
How Long Does Urolithin A Take to Work?
This depends on what you mean by “work.”
Human trials typically evaluate outcomes after:
- Several weeks
- Several months
Changes in biomarkers may occur on a different timeline from:
- Strength
- Endurance
- Physical performance
There is no evidence-based promise that users should feel a noticeable effect after a specific number of days.
Should You “Feel” Urolithin A?
Not necessarily.
Urolithin A is not a stimulant.
It should not be expected to create an immediate caffeine-like sensation.
A person not feeling an acute effect does not prove:
- No absorption
- No biological activity
Conversely, feeling more energetic does not prove improved mitochondrial function.
Subjective sensation and biological outcome are not equivalent.
Is Urolithin A Safe?
Available human trials generally report favorable short-term tolerability.
In the first-in-human study, Urolithin A was administered over several dose ranges and was generally well tolerated under study conditions.
The older-adult randomized trial also reported no significant difference in adverse events between Urolithin A and placebo.
However:
short-term trial safety is not the same as proven lifelong safety.
How Long Has Urolithin A Been Studied in Humans?
Most intervention trials remain relatively short.
The 2024 systematic review included studies lasting approximately:
28 days to 4 months.
That means evidence for:
- Years of continuous use
- Decades of use
- Lifelong supplementation
is not established.
Can Urolithin A Affect the Liver or Kidneys?
Current human trials have not established a common clinically significant liver- or kidney-toxicity signal in healthy study participants under studied conditions.
But people with:
- Significant liver disease
- Significant kidney disease
- Complex medical conditions
should not assume healthy-volunteer data automatically apply to them.
Does Urolithin A Interact With Medications?
Comprehensive human drug-interaction data remain limited.
This is especially important because many supplement trials exclude participants with:
- Complex disease
- Extensive medication use
If you take prescription medication or have significant medical conditions, individualized guidance is appropriate.
Urolithin A and Cancer
Preclinical research has explored Urolithin A in cancer-related models.
But much of this evidence comes from:
- Cell studies
- Animal models
A 2026 systematic review of colorectal-cancer research emphasized that existing evidence in that area remains predominantly preclinical and requires human clinical trials.
Urolithin A should not be marketed as:
- A cancer treatment
- A cancer-prevention therapy
- An alternative to oncology care
Urolithin A and Brain Health
Research is emerging around:
- Neuroinflammation
- Neurodegenerative models
- Mitochondrial quality control in the nervous system
But current evidence does not establish Urolithin A as a treatment for:
- Alzheimer’s disease
- Parkinson’s disease
- Dementia
Preclinical mechanisms should not be converted into clinical promises.
Who Might Be Interested in Urolithin A?
Urolithin A may appeal to adults interested in:
- Mitochondrial biology
- Healthy aging research
- Muscle endurance
- Maintaining an active lifestyle with age
But supplements should remain secondary to:
- Exercise
- Nutrition
- Sleep
- Management of medical risk factors
Who Should Be More Cautious?
Consider individualized guidance if you:
- Are pregnant or breastfeeding
- Take multiple prescription medications
- Have significant liver disease
- Have significant kidney disease
- Have active cancer
- Are receiving cancer treatment
- Have another complex medical condition
Human safety data remain more limited in these populations.
Does Everyone Over 50 Need Urolithin A?
No.
Age alone does not create a nutritional requirement for Urolithin A.
After 50, interventions with much stronger evidence include:
- Resistance training
- Regular physical activity
- Adequate protein
- Cardiovascular fitness
- Good sleep
- Blood-pressure control
- Lipid management
- Glucose management
Urolithin A should be viewed as an optional research-backed supplement, not a foundation of healthy aging.
Urolithin A After 60
The compound may be particularly interesting because some human trials included older adults.
However:
interest is not the same as necessity.
Older age also increases the likelihood of:
- Multiple medications
- Chronic disease
- Kidney impairment
- Liver impairment
so supplement decisions can require more individualized review.
Is Urolithin A Worth Taking?
There is no universal answer.
Reasons someone may consider it include:
- Interest in emerging mitochondrial research
- Interest in muscle-aging research
- Inability to reliably produce Urolithin A from dietary precursors
Reasons for caution include:
- Cost
- Limited long-term evidence
- Small overall human evidence base
- Uncertainty about meaningful clinical outcomes
The evidence is substantially more credible than many purely speculative “longevity” compounds.
But it is not strong enough to call Urolithin A a proven anti-aging intervention.
The Evidence Hierarchy
When evaluating Urolithin A claims, it helps to separate:
Stronger Evidence
- Human bioavailability
- Short-term tolerability
- Effects on selected mitochondrial-related biomarkers
- Some muscle-endurance and strength findings
Emerging Evidence
- Broader physical-performance benefit
- Long-term muscle preservation
- Functional aging
Not Established
- Human lifespan extension
- Reversal of aging
- Dementia prevention
- Cancer treatment
- Universal improvement in mitochondrial ATP production
- Guaranteed energy improvements
Why Industry Funding Matters
Several important Urolithin A trials have involved companies developing commercial Urolithin A products.
That does not invalidate the findings.
But conflicts of interest and study sponsorship should be considered when evaluating evidence.
Independent replication remains valuable.
Celnovix therefore evaluates:
- Study design
- Primary versus secondary outcomes
- Sample size
- Statistical significance
- Funding
- Replication
rather than relying on marketing summaries.
The Bottom Line
Urolithin A is a gut microbiome-derived metabolite produced from dietary compounds found in foods such as:
- Pomegranates
- Walnuts
- Berries
Its scientific importance comes primarily from research involving:
mitophagy and mitochondrial quality control.
Human clinical trials have shown that Urolithin A is bioavailable and can influence:
- Mitochondrial-related biomarkers
- Muscle endurance
- Selected strength measures
- Inflammatory biomarkers
But results are mixed.
Some important primary outcomes—including:
- Six-minute walking distance
- Maximal ATP production
- Peak power
have not consistently improved versus placebo.
The current evidence therefore supports describing Urolithin A as:
an emerging, biologically active compound with promising human research around mitochondrial quality control and selected muscle outcomes.
It does not support describing it as:
- A proven longevity therapy
- A mitochondrial cure
- A treatment for sarcopenia
- A guaranteed energy booster
- A compound proven to extend human lifespan
For healthy aging, the foundation remains:
- Exercise
- Nutrition
- Sleep
- Muscle preservation
- Cardiometabolic health
Urolithin A may complement those foundations.
It should not replace them.
Frequently Asked Questions
What is Urolithin A?
Urolithin A is a metabolite produced when certain gut bacteria metabolize ellagitannins and ellagic acid from foods such as pomegranates and walnuts.
Is Urolithin A naturally found in food?
Usually not in meaningful amounts as free Urolithin A. Foods primarily provide ellagitannin and ellagic-acid precursors that gut microbes can convert into Urolithin A.
What does Urolithin A do?
It is primarily studied for its relationship with mitophagy, mitochondrial quality control, muscle endurance and selected mitochondrial biomarkers.
What is mitophagy?
Mitophagy is the selective cellular process through which damaged or dysfunctional mitochondria are identified and recycled.
Does everyone produce Urolithin A naturally?
No. Natural production varies substantially between individuals because the gut microbiome differs from person to person.
Does Urolithin A increase energy?
It participates in research involving mitochondrial biology, but human evidence does not establish it as a predictable acute energy booster.
Does Urolithin A build muscle?
It is not established as a muscle-building supplement. Some human trials report selected strength and endurance improvements.
Does Urolithin A reverse aging?
No. Human evidence does not show that Urolithin A reverses aging.
Does Urolithin A extend lifespan?
This has not been demonstrated in humans.
Is Urolithin A safe?
Short-term human trials generally report favorable tolerability, but long-term evidence remains limited.
How much Urolithin A should you take?
Human studies have used several doses, commonly including 500 mg and 1,000 mg/day, but research doses are not universal personal recommendations.
Is Urolithin A better than NMN?
They target different biology. NMN is primarily associated with NAD+ metabolism, while Urolithin A is primarily studied around mitophagy and mitochondrial quality control.
Related Celnovix Guides
- Urolithin A Benefits: What Does the Research Show?
- Best Time to Take Urolithin A: Morning or Night?
- Urolithin A Dosage Guide: How Much Should You Take?
- Foods Rich in Urolithin A: Natural Sources and What to Know
- Urolithin A vs Resveratrol: Which Should You Choose?
- Urolithin A vs CoQ10: What’s the Difference?
- NMN vs Urolithin A: Which Is Better for Healthy Aging?
- Can You Take NMN and Urolithin A Together?
- How to Maintain Muscle Mass After 50
References
Hodzic Kuerec A, et al.
Targeting Aging With Urolithin A in Humans: A Systematic Review
This 2024 systematic review identified five human studies involving approximately 250 healthy participants.
Urolithin A supplementation was associated with changes in selected:
- Mitochondrial pathways
- Autophagy markers
- Inflammatory markers
- Muscle-strength and endurance outcomes
But several measures of overall physical function and mitochondrial performance did not significantly improve.
View the systematic review on PubMed
Andreux PA, et al.
The Mitophagy Activator Urolithin A Is Safe and Induces a Molecular Signature of Improved Mitochondrial and Cellular Health in Humans
This first-in-human study evaluated single and repeated Urolithin A dosing in healthy sedentary older adults.
Urolithin A was bioavailable and generally well tolerated under study conditions.
Repeated supplementation influenced:
- Skeletal-muscle mitochondrial gene expression
- Plasma acylcarnitine profiles
Liu S, et al.
Effect of Urolithin A Supplementation on Muscle Endurance and Mitochondrial Health in Older Adults: A Randomized Clinical Trial
This randomized trial enrolled 66 adults aged 65–90.
Participants received 1,000 mg/day of Urolithin A or placebo for four months.
Selected muscle-endurance and biomarker outcomes improved.
However, the study’s primary outcomes involving six-minute walking distance and maximal ATP production did not significantly improve versus placebo.
Singh A, et al.
Urolithin A Improves Muscle Strength, Exercise Performance, and Biomarkers of Mitochondrial Health in a Randomized Trial in Middle-Aged Adults
This randomized trial evaluated 500 mg and 1,000 mg/day of Urolithin A in middle-aged adults.
Selected strength, exercise and mitochondrial-related outcomes improved.
However, peak power output—the primary endpoint—did not significantly improve.
Effects of Urolithin A Supplementation on Muscle Health Outcomes in Humans From Randomized Controlled Trials
2026 Systematic Review and Meta-Analysis
This analysis reviewed randomized controlled trials published through December 2025.
Quantitative pooling was possible primarily for the six-minute walk test.
The pooled estimate suggested a possible improvement, but the confidence interval crossed zero and the overall result was not statistically significant.
The certainty of evidence was low.
View the meta-analysis on PubMed
Evidence Transparency Note
The Urolithin A evidence base has several important limitations:
- Human trials remain relatively small.
- Most interventions last only weeks to months.
- Several studies involve commercial Urolithin A developers or industry funding.
- Primary and secondary outcomes do not always point in the same direction.
- Findings from healthy or relatively healthy study participants may not generalize to people with chronic disease.
- Biomarker changes do not automatically translate into clinically meaningful improvements.
Celnovix therefore distinguishes between:
- Mechanistic evidence
- Biomarker changes
- Functional outcomes
- Proven clinical benefit
Editorial Standards
Celnovix publishes evidence-informed educational content about supplements, nutrition, healthy aging and cellular biology.
For Urolithin A content, we prioritize:
- Human randomized controlled trials
- Systematic reviews and meta-analyses
- Human pharmacology studies
- Mechanistic evidence when clearly identified as such
We do not interpret:
mitophagy activity
as automatically meaning:
human age reversal.
We also distinguish between:
- Primary endpoints
- Secondary endpoints
- Within-group changes
- Statistically significant differences versus placebo
because these distinctions materially affect how supplement evidence should be interpreted.
Medical Disclaimer
This article is provided for general educational and informational purposes only and is not intended as medical advice, diagnosis, prevention or treatment.
Urolithin A is not established as a treatment for:
- Sarcopenia
- Mitochondrial disease
- Cancer
- Dementia
- Cardiovascular disease
- Other medical conditions
Clinical-study doses should not automatically be interpreted as individualized supplementation recommendations.
If you are pregnant or breastfeeding, take prescription medication, are receiving treatment for cancer, have significant kidney or liver disease, or have another complex medical condition, discuss supplement use with an appropriately qualified healthcare professional.
